Dr. Sterling Bennett, the Medical Director of Intermountain Healthcare's Central lab is here to explain the Fecal Immunochemical Test (FIT). A Fecal Immunochemical Test is meant to detect blood in a ...
The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...
Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...
Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...
Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...
Colorectal cancer has been receiving more attention in recent months. It is the third most commonly diagnosed cancer in men ...
Colorectal cancer rates are rising in adults under 50. A Holland Hospital physician assistant explains how screening and diet ...
Please provide your email address to receive an email when new articles are posted on . In a prospective study, researchers enrolled 457 asymptomatic participants (mean age 61.4 years; 75% women) from ...
Dear Dr. Roach: I am a 74-year-old male, and I recently received a negative result from my mail-in fecal test. I have been on an every-five-years colonoscopy cycle for the past 20 years (noncancerous ...
VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...
Please provide your email address to receive an email when new articles are posted on . Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results